| Static and dynamic cognitive reserve proxy measures: interactions with Alzheimer’s disease neuropathology and cognition M Malek-Ahmadi, S Lu, YY Chan, SE Perez, K Chen, EJ Mufson Journal of Alzheimer's disease & Parkinsonism 7 (6), 2017 | 35 | 2017 |
| PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation P Khadka, ZJ Reitman, S Lu, G Buchan, G Gionet, F Dubois, DM Carvalho, ... Nature communications 13 (1), 604, 2022 | 26 | 2022 |
| Cognitive domain dispersion association with Alzheimer’s disease pathology M Malek-Ahmadi, S Lu, YY Chan, SE Perez, K Chen, EJ Mufson Journal of Alzheimer's Disease 58 (2), 575-583, 2017 | 21 | 2017 |
| FOXR2 is an epigenetically regulated pan-cancer oncogene that activates ETS transcriptional circuits JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Cancer research 82 (17), 2980-3001, 2022 | 8 | 2022 |
| [P2–434]: INTELLECTUAL FUNCTION VERSUS YEARS OF EDUCATION AS COGNITIVE RESERVE PROXIES: INTERACTION WITH ALZHEIMER's DISEASE NEUROPATHOLOGY AND IMPACT ON EPISODIC MEMORY AND … M Malek‐Ahmadi, S Lu, YY Chan, SE Perez, K Chen, EJ Mufson Alzheimer's & Dementia 13 (7S_Part_16), P802-P802, 2017 | 1 | 2017 |
| DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS J Tsai, P Cejas, M Coppola, D Wang, S Patel, D Wu, P Arounleut, X Wei, ... Neuro-Oncology 25 (Supplement_1), i17-i17, 2023 | | 2023 |
| Dissecting mechanisms underlying FOXR2-mediated gliomagenesis in diffuse midline gliomas JW Tsai, P Cejas, M Coppola, DK Wang, S Patel, DW Wu, P Arounleut, ... Cancer Research 83 (7_Supplement), 3562-3562, 2023 | | 2023 |
| FOXR2 is an oncogenic driver across adult and pediatric cancers JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Cancer Research 82 (12_Supplement), 5730-5730, 2022 | | 2022 |
| DIPG-54. p53 pathway reactivation as a therapeutic strategy in diffuse intrinsic pontine glioma L Lupien, V Rendo, E Morin, N Khuu, J DiGiacomo, P Khadka, M Chacon, ... Neuro-Oncology 24 (Suppl 1), i31, 2022 | | 2022 |
| RARE-22 Characterizing the landscape of structural variants in adamantinomatous craniopharyngioma D Jomaa, P Khadka, D Novikov, AL Condurat, JW Tsai, F Dubois, ... Neuro-Oncology 24 (Supplement_1), i14-i14, 2022 | | 2022 |
| DIPG-19. FOXR2 is an oncogenic driver across pediatric and adult cancers JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Neuro-Oncology 24 (Supplement_1), i21-i22, 2022 | | 2022 |
| OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF HIGH-GRADE GLIOMA V Rendo, L Lupien, N Khuu, K Pelton, L Elcavage, S Lu, P Khadka, ... NEURO-ONCOLOGY 23, 77-77, 2021 | | 2021 |
| OMRT-6. Optimizing MDM2 inhibition for the treatment of high-grade glioma V Rendo, L Lupien, N Khuu, K Pelton, S Lu, P Khadka, J Langhnoja, ... Neuro-Oncology Advances 3 (Supplement_2), ii8-ii8, 2021 | | 2021 |
| DIPG-22. DISSECTING THE ONCOGENIC ROLE OF FOXR2 IN DIFFUSE INTRINSIC PONTINE GLIOMA JW Tsai, SK Patel, H Bear, F Dubois, P Khadka, S Lu, E Gonzalez, ... Neuro-Oncology 22 (Supplement_3), iii291-iii291, 2020 | | 2020 |
| RARE-07. THE LANDSCAPE OF GENOMIC ALTERATIONS IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS P Khadka, E Prince, S Lu, S Santagata, K Ligon, P Manley, R Beroukhim, ... Neuro-Oncology 22 (Suppl 3), iii443, 2020 | | 2020 |
| DIPG-53. CHARACTERIZING THE ROLE OF PPM1D MUTATIONS IN THE PATHOGENESIS OF DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGS) P Khadka, Z Reitman, S Lu, G Buchan, R Hartley, H Bear, Y Georgis, ... Neuro-Oncology 22 (Suppl 3), iii297, 2020 | | 2020 |
